Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

ClinicalTrials.gov ID: NCT00206180

Public ClinicalTrials.gov record NCT00206180. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 2:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Randomized Trial of the Relationship of Intragastric Acid Control and Healing Status of Moderate and Severe Erosive Esophagitis After Treatment With Esomeprazole Magnesium (NEXIUM®) 10 mg and 40 mg Once Daily

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to decide if controlling stomach acid is related to healing of erosive esophagitis after treatment with esomeprazole magnesium (NEXIUM®) 10 mg and 40 mg once daily.

Study identification

NCT ID
NCT00206180
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AstraZeneca
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2004 (Type not available)
Primary completion
Not listed
Completion
Aug 2005 (Actual)
Last update posted
Mar 26, 2009

2004 – 2005

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Research Site Alabaster Alabama — —
Research Site Anaheim California — —
Research Site Dinuba California — —
Research Site Fresno California — —
Research Site Orange California — —
Research Site San Diego California — —
Research Site Bridgeport Connecticut — —
Research Site Fort Lauderdale Florida — —
Research Site Hialeah Florida — —
Research Site Jacksonville Florida — —
Research Site Miami Florida — —
Research Site New Port Richey Florida — —
Research Site Zephyrhills Florida — —
Research Site Decatur Georgia — —
Research Site Rome Georgia — —
Research Site Savannah Georgia — —
Research Site Oakbrook Terrace Illinois — —
Research Site Urbana Illinois — —
Research Site Louisville Kentucky — —
Research Site Covington Louisiana — —
Research Site Baltimore Maryland — —
Research Site Chevy Chase Maryland — —
Research Site Kalamazoo Michigan — —
Research Site Troy Michigan — —
Research Site Egg Harbor New Jersey — —
Research Site Passaic New Jersey — —
Research Site Brooklyn New York — —
Research Site New York New York — —
Research Site Chapel Hill North Carolina — —
Research Site Jacksonville North Carolina — —
Research Site Duncansville Pennsylvania — —
Research Site Pittsburgh Pennsylvania — —
Research Site North Providence Rhode Island — —
Research Site Knoxville Tennessee — —
Research Site Dallas Texas — —
Research Site Ogden Utah — —
Research Site Bellevue Washington — —
Research Site Spokane Washington — —
Research Site Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00206180, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2009 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00206180 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →